The 6th Annual ASTS Leadership Development Program, September 27-30, was another smashing success, with sessions on business topics in transplantation generating lots of great feedback. A lunar eclipse viewing added some fun to the educational and networking activities. Surgeons, administrators, and nurses were joined by representatives from industry and OPOs to learn about the business side of transplant centers.
Among the speakers was Jeremy Goodman, MD, MBA, who was an early attendee of the LDP and was inspired to get his MBA after participating. His entertaining talk on ICD-10 was so well received that ASTS recruited him to give a webinar on the same topic the following month. The webinar is archived on the ASTS website.
Frank Opelka, MD, of the American College of Surgeons spoke about the Medicare Access and CHIP Reauthorization Act (MACRA), which repealed the SGR and replaces the PQRS with a new quality measurement framework. Both ACS and ASTS have submitted extensive comments on the MACRA RFI issued by CMS in hopes of helping shape the new quality programs in a way that makes sense for transplant surgeons.
ASTS thanks the sponsors of this year’s Leadership Development Program, Novartis Pharmaceuticals and Genentech, a member of the Roche Group.
The 7th Annual Leadership Development Program will be September 11-14, 2016 at the Kellogg School of Management at Northwestern University. To be put on the early interest list, contact Laurie Kulikosky at email@example.com.
“The ASTS LDP was very meaningful, informative, and well organized. It has stimulated my interest in management and business that fills the gaps in whole picture of transplantation. I have decided to do my MBA…. Thank you for the opportunity and good insight that faculty provided.”
Bekir Tanriover, MD, MPH
Assistant Professor, Division of Nephrology
UT Southwestern Medical Center